Deutsch
TU Dresden

search
From the biology of stem cells to mathematical modeling of brain function – Prof. Federico Calegari receives prestigious grant of the VolkswagenStiftung
The brain is our most complex organ. Of many, learning and memory are among the most studied cognitive functions in all animals. Yet, despite the enormous progress in the study of the molecular,... [read more]
Cells in mouse tooth © CRTD
Happy Birthday, Alexander von Humboldt!
On September 14, 1769, Alexander von Humboldt was born – just 250 years ago. CRTD and its Humboldt-Professor Michael Sieweke reflect on a great discoverer and networker [read more]
©Alexander-von-Humboldt-Stiftung
Welcome Dr. Natalia Rodríguez Muela as new Research Group Lead at CRTD
The successful recruitment of this internationally renowned scientist is a result of the joint efforts of the German Center for Neurodegenerative Diseases (DZNE), the Center for Regenerative... [read more]
Breaching the brain’s defense causes epilepsy
Scientific study proves the relevance of glial cells for epileptic seizures and shows potential for new therapies. Epileptic seizures can happen to anyone. But how do they occur and what... [read more]
© Emre Yaksi Lab, NTNU
100 000 babies screened for increased type 1 diabetes risk in Freder1k Study
Researchers from Dresden contribute to international success [read more]
Arthur is screening participant 100,000 © CRTD
TU Dresden retains its title as University of Excellence
Everybody at our university is excited: TU Dresden has received permanent funding as a University of Excellence! [read more]
© Amac Garbe
Summer University at CRTD
Stem cells & sensory organs - this was the motto... [read more]
© CRTD
13th CRTD Summer Conference offered great scientific exchange
180 scientists and company representatives assembled on June 28, 2019 [read more]
Summer Conference © CRTD

Research at the Center for Regenerative Therapies (CRTD) at TU Dresden focuses on discovering principles of cell and tissue regeneration, and leveraging this for recognition, treatment, and reversal of diseases. The CRTD is well positioned for this challenge with its diversity in model organisms, organs, and disease systems and its range of methodological approaches from basic research to validation projects and clinical studies. The CRTD links the bench to the clinic, and scientists to clinicians to bring expertise in stem cells, gene-editing, and regeneration towards innovative therapies for metabolic, osteo-hematological, and neurological diseases.